Protocols

GYNECOLOGIC ONCOLOGY PROTOCOLS: 02/03/2014 

OVARIAN                       

GOG-0241:     A GCIG Intergroup Mulitcenter Phase III Trial of Open Label Carboplatin and Paclitaxel +/- NCISupplied Bevacizumab (NSC #704865, IND #7921) Compared with Oxaliplatin and Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients with Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC) (SUSPENDED)

GOG-0260:    A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IND# 110072)

11-GYN-098: Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (Miller)

OVB-2003:     Biomarker Discovery in Ovarian Tumors and Other Gynecologic Conditions

ENDOMETRIAL

GOG-0238:     A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-only Recurrence of Carcinoma of the Uterine Corpus

GOG-0258:     A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma

GOG-0261:     A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy Naive Patients with Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus, Fallopian Tube, Peritoneum or Ovary (*uterus only after 10/21/13)

GOG-229-O:   A Randomized Phase II Study with a Phase I Lead-in to Assess the Antitumor Eefficacy of the MEK Inhibitor Trametinib Alone or in Combination with GSK2141795, an AKT Inhibitor in Patients with Recurrent or Persistent Endometrial Cancer (Opening Soon)

11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation     to Determine Extent of Surgical Staging (Ueland)

 CERVIX

 GOG-0263:     Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy

 GOG-0274:     A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: THE OUTBACK TRIAL